Skip to main content
    C

    CLARIVATE PLC (CLVT)

    Official site

    TECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NYSE

    $2.30
    -0.03 (-1.29%)

    Market Cap: $1.49B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CLARIVATE PLC (CLVT) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    CLARIVATE (CLVT) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, CLARIVATE reported EPS of $0.20, above the $0.16 estimate. It beat the EPS estimate in each of the last 10 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    70%(26/37)
    Avg Surprise
    +4.36%
    Streak
    10 Q

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.17
    Range$0.13 - $0.22
    10 analysts
    Revenue Consensus
    $507.95M
    Range$470.44M - $535.50M
    8 analysts
    Reports Apr 27, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.14
    Range$0.03 - $0.17
    8 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.15-11.2%
    60d ago$0.15-11.2%
    30d ago$0.15-11.2%
    7d ago$0.15-12.1%
    Current$0.14
    Revenue Consensus
    $494.73M
    Range$483.10M - $508.81M
    6 analysts

    Next Report

    CLVT has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 15.0% below the $0.20 reported for the quarter ended Dec 31, 2025.

    CLVT Earnings Call

    The latest CLVT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 37 quarters below that had an estimate, CLVT beat 26, missed 7 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $481.60M, down 9.2% from $530.30M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.20$0.16$0.16 - $0.21+25.00%Beat+11.1%30 up, 2 downNov 3, 2026$481.60M
    Jun 30, 2026$0.17$0.14N/A+21.43%Beat-5.6%81 up, 6 downJul 29, 2026$587.30M
    Mar 31, 2026$0.18$0.14$0.12 - $0.16+28.57%Beat+28.6%90 up, 1 downApr 29, 2026$585.50M
    Dec 31, 2025$0.20$0.17$0.15 - $0.18+20.63%Beat-4.8%90 up, 1 downFeb 24, 2026$617.00M
    Sep 30, 2025$0.18$0.16$0.14 - $0.17+12.50%Beat-5.3%91 up, 1 downOct 29, 2025$530.30M
    Jun 30, 2025$0.18$0.17$0.16 - $0.20+5.88%Beat-10.0%91 up, 0 downJul 30, 2025$621.40M
    Mar 31, 2025$0.14$0.12$0.10 - $0.13+16.67%Beat0.0%90 up, 1 downApr 29, 2025$593.70M
    Dec 31, 2024$0.21$0.20$0.18 - $0.22+3.75%Beat-8.7%91 up, 6 downFeb 19, 2025$663.00M
    Sep 30, 2024$0.19$0.18$0.17 - $0.20+5.56%Beat-9.5%90 up, 1 downNov 6, 2024$622.20M
    Jun 30, 2024$0.20$0.18$0.17 - $0.20+11.11%Beat-4.8%100 up, 1 downAug 6, 2024$650.30M
    Mar 31, 2024$0.14$0.14$0.13 - $0.150.00%In line-22.2%100 up, 0 downMay 8, 2024$621.20M
    Dec 31, 2023$0.23$0.21$0.19 - $0.23+9.52%Beat+4.5%110 up, 0 downFeb 27, 2024$683.70M
    Sep 30, 2023$0.21$0.18$0.16 - $0.20+16.67%Beat+5.0%112 up, 0 downNov 7, 2023$647.20M
    Jun 30, 2023$0.21$0.20$0.17 - $0.24+5.00%Beat-4.5%111 up, 0 downAug 3, 2023$668.80M
    Mar 31, 2023$0.18$0.15$0.13 - $0.17+20.00%Beat-14.3%90 up, 0 downMay 9, 2023$629.10M
    Dec 31, 2022$0.22$0.17$0.12 - $0.20+29.41%Beat-4.3%80 up, 0 downMar 1, 2023$675.30M
    Sep 30, 2022$0.20$0.17$0.16 - $0.21+17.65%Beat+25.0%80 up, 0 downNov 8, 2022$635.70M
    Jun 30, 2022$0.22$0.20$0.19 - $0.23+10.00%Beat+29.4%90 up, 0 downAug 9, 2022$686.60M
    Mar 31, 2022$0.21$0.18$0.15 - $0.21+16.67%Beat+50.0%80 up, 0 downMay 9, 2022$662.20M
    Dec 31, 2021$0.23$0.21$0.17 - $0.24+9.52%Beat+4.5%9N/AMar 10, 2022$560.70M
    Sep 30, 2021$0.16$0.16$0.12 - $0.190.00%In line+14.3%8N/AOct 28, 2021$442.10M
    Jun 30, 2021$0.17$0.17$0.15 - $0.180.00%In line-5.6%6N/AJul 29, 2021$445.70M
    Mar 31, 2021$0.14$0.12$0.11 - $0.18+16.67%Beat+100.0%6N/AMay 10, 2021$428.40M
    Dec 31, 2020$0.22$0.17$0.14 - $0.18+29.41%Beat+69.2%5N/AFeb 25, 2021$455.65M
    Sep 30, 2020$0.14$0.15$0.13 - $0.16-6.67%Miss0.0%7N/AOct 29, 2020$284.36M
    Jun 30, 2020$0.18$0.14$0.13 - $0.16+28.57%BeatN/A6N/AJul 30, 2020$273.50M
    Mar 31, 2020$0.07$0.09$0.07 - $0.13-22.22%MissN/A5N/AMay 4, 2020$240.59M
    Dec 31, 2019$0.13$0.16$0.12 - $0.19-18.75%MissN/A4N/AFeb 27, 2020$255.01M
    Sep 30, 2019$0.14$0.06$0.01 - $0.15+133.33%BeatN/A2N/ANov 5, 2019$243.00M
    Jun 30, 2019-$0.04-$0.18-$0.18 - $0.15+77.78%BeatN/A3N/AAug 7, 2019$242.31M
    Mar 31, 2019-$9.69$0.12N/AN/AN/AN/AN/AN/AApr 26, 2019$234.03M
    Dec 31, 2018-$0.09$0.16N/A-156.25%Miss-160.0%N/AN/AFeb 27, 2019$245.25M
    Sep 30, 2018-$0.01$0.19N/A-105.26%Miss-105.9%N/AN/ANov 5, 2018$242.90M
    Jun 30, 2018Not reported$0.15N/AN/ANot reportedN/AN/AN/AAug 3, 2018$243.30M
    Mar 31, 2018Not reported$0.14N/AN/ANot reportedN/AN/AN/AJun 29, 2018$237.03M
    Dec 31, 2017$0.15$0.15$0.14 - $0.160.00%In line-6.3%2N/AMar 30, 2018$619.81M
    Sep 30, 2017$0.17$0.16$0.16 - $0.17+6.25%Beat+30.8%4N/ANov 6, 2017N/A
    Jun 30, 2017$0.14$0.19N/A-26.32%Miss-6.7%5N/AAug 4, 2017N/A
    Mar 31, 2017$0.02$0.16N/A-87.50%Miss-81.8%N/AN/AMay 9, 2017N/A
    Dec 31, 2016$0.16$0.15N/A+6.67%Beat+6.7%N/AN/AFeb 24, 2017$514.25M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.70, within 4 cents of the year before. It was $0.55 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.70N/A
    Dec 31, 2024$0.74-10.8%
    Dec 31, 2023$0.83N/A
    Dec 31, 2022$0.85+21.4%
    Dec 31, 2021$0.70+14.8%
    Dec 31, 2020$0.61N/A
    Dec 31, 2019-$9.46N/A
    Dec 31, 2018-$0.10-120.8%
    Dec 31, 2017$0.48-12.7%
    Dec 31, 2016$0.55N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,200 words across 7 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20264,2227
    2026Q2Jun 30, 20265,0789
    2026Q1Mar 31, 20265,89711
    2025Q4Dec 31, 20256,08011
    2025Q3Sep 30, 20255,98410
    2025Q2Jun 30, 20253,48610
    2025Q1Mar 31, 20254,94810
    2024Q4Dec 31, 20246,30112

    2026Q3 Earnings Call

    Opening remarks

    Mark Donohue Vice President, Investor Relations Thank you, and good morning, everyone. Thank you for joining us for the Clarivate Third Quarter 2026 Earnings Conference Call. As a reminder, this conference call is being recorded and webcast and is copyrighted property of Clarivate. Any rebroadcast of this information in whole or in part without prior written consent of Clarivate is prohibited. The accompanying earnings call presentation is available on the Investor Relations section of the company's website. During our call, we may make certain forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the business or developments in Clarivate's business to differ materially from the anticipated results, performance, achievements or developments expressed or implied by such forward-looking statements. Information about the factors that could cause actual results to differ materially from anticipated results or performance can be found in Clarivate's filings with the SEC and on the company's website. Our discussion will include non-GAAP measures or adjusted numbers. Clarivate believes non-GAAP results are useful in order to enhance the understanding of our ongoing operating performance, but they are a supplement to and should not be considered in isolation from or as a substitute for GAAP financial measures. Reconciliations of these measures to GAAP measures are available in our earnings release and supplemental presentation on our website. With me today are Matti Shem Tov, Chief Executive Officer; and Michael Easton, Chief Financial Officer. After our prepared remarks, we'll open up the call to your questions. And with that, it's a pleasure to turn the call over to Matti.

    Matti Shem Tov CEO Thank you, Mark, and thank you, everyone, for joining us. The third quarter marks a major milestone in Clarivate's continued transformation. We completed the strategic sale of the Life Sciences & Healthcare segment ahead of schedule. This positions Clarivate as a more focused, higher-quality recurring business, centered on 2 scaled market-leading segments, Academia & Government and IP. Both segments are driving commercial traction and customer validation from our AI-led innovation. Web of Science Research Intelligence and IPOne are strong examples of that innovation in practice. I will discuss this in more detail later. In Q2, we said that we had the building blocks in place to accelerate organic growth. The progress we made this quarter is proof that we delivered on our commitments. Today's message is straightforward. We have a clear path to accelerating sustained organic growth, expanding free cash flow and reducing leverage, all of which will continue to create long-term value for shareholders.

    Frequently Asked Questions About CLVT

    When is CLARIVATE's next earnings date?

    CLARIVATE's next earnings report is expected for Feb 22, 2027.

    Did CLVT beat earnings estimates last quarter?

    Yes. CLARIVATE reported EPS of $0.20 for the quarter ended Sep 30, 2026, above the $0.16 estimate, a 25.00% surprise.

    What EPS do analysts expect from CLVT next quarter?

    The consensus EPS estimate for CLARIVATE for the quarter ending Dec 31, 2026 is $0.17 from 10 analysts, with estimates from $0.13 to $0.22.

    How often does CLVT beat earnings estimates?

    CLARIVATE beat the EPS estimate in each of the last 10 quarters, with an average surprise of +15.11%.